Arterium becomes the owner of the Alteyca brand in Belarus
Arterium Corporation became the owner of the Alteyca brand in Belarus. This brand gives green light to registration and subsequent promotion on Belarusian market of another popular, time-tested pharmaceutical drug of Arterium.
Now, the drug’s registration file must pass examination at the Healthcare Ministry of Belarus, and after that, Arterium will be issued a registration certificate and able to sell the drug in this country. Registration takes about 10 months on average.
According to the head of the Corporation’s representative office in Belarus Viktor Zalevskiy, plant-based medicinal products are quite popular among the population of this country. Mr. Zalevskiy hopes that Belarusian consumers will appreciate Alteyca as highly as the already-popular over-the-counter drugs like Sedavit and Difluzol.
Presently, Arterium actively promotes 10 drugs in the Republic of Belarus. The most popular of them are Thiotriazolin, L-lysine aescinate® and Sonnat.